Spartanburg County will receive 60 Opiate Overdose Kits, valued at more than $6,000, from Smith Drug Co. Read More »

Charles Holley Jr. has joined the Amgen Board of Directors as a member of the Audit Committee and the Corporate Responsibility and Compliance Committee.  Read More »

Renova Therapeutics Inc. recently entered an alliance with Janssen Pharmaceuticals Inc. for the development of new treatments for congestive heart failure and Type 2 diabetes. Read More »

Five speakers to the Parenteral Drug Association Pharmaceutical Quality Metrics and Culture Conference have been named.  Read More »

The National Association of Specialty Pharmacy recently made a new app available for members only.  Read More »

The U.S. Food and Drug Administration has accepted Intarcia Therapeutics' New Drug Application for ITCA 650, which can be used to treat Type 2 diabetes.  Read More »

Teva Pharmaceutical Industries Ltd., recently announced their intent to market a new drug in the U.S.  Read More »

Biotechnology company Acorda Therapeutics Inc., which is known for its work in neurological disorders, will present at two investor conferences this month.  Read More »

Kroger will sell Narcan nasal spray in its Dallas and Houston stores, without the need of a prescription.  Read More »

President Trump recently met with pharmaceutical executives concerning the prices of drugs and the regulations surrounding them. Read More »

Digital Pharmacist Inc. was launched Jan. 31 after the strategic merger of TeleManager Technologies Inc. and RxWiki Inc. Read More »

Sanofi has received FDA approval of Xyzal Allergy 24HR, an over-the-counter option for those suffering with certain allergies.  Read More »

Blue Shield of California and OptumRX will co-sponsor agricultural trade organization UnitedAg's 37th Annual Meeting and Conference in Napa, California, March 14-17. Read More »

Access to affordable and dependable health care for women has become  growing issue, and one facility says that it is prepared to play a big role in the solution in making women’s health care more accessible. Read More »

The U.S. Food and Drug Administration released its final guidance on naming biologics and biosimilars. Read More »

Systech International's Serialized by November program helped numerous manufacturers comply with the standards outlined in the Drug Supply Chain Security Act before its deadline. Read More »

CTI BioPharma Corp., a company that specializes in developing blood cancer treatments, has named Michael Metzger its new director. Read More »

Relmada Therapeutics, a biopharmaceutical company that specializes in developing treatments for central nervous system diseases, received approval from the U.S. Food and Drug Administration to advance a new therapy to clinical trials. Read More »

The U.S. Food and Drug Administration has approved Linzess, a treatment for people suffering with chronic idiopathic constipation. Read More »

DePuy Synthes and Pacira Pharmaceuticals have entered into a partnership to promote pain reliever Exparel. Read More »